Dr. David Alan Sweetser MD
Hematologist (Pediatric) | Pediatric Hematology-Oncology
55 Fruit St Yaw 8b Pediatric Hematology Boston MA, 02114About
Dr. David Sweetser is a pediatric hematologist practicing in Boston, MA. Dr. Sweetser specializes in treating children that have a blood disease or cancer. Such blood diseases include disorders of red blood cells, white blood cells and/or platelets. The types of cancers that Dr. Sweetser treats include leukemias, lymphomas and certain tumors. Dr. Sweetser can also treat bleeding disorders in children. Pediatric hematologists can be found in childrens hospitals, community hospitals, university medical centers and more.
Education and Training
WASHINGTON UNIV IN ST LOUIS SCH OF MED 1989
Washington Center / School of Medicine 1989
Washington University in St. Louis School of Medicine 1989
Board Certification
Medical GeneticsAmerican Board of Medical GeneticsABMG
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival.
- Discovering chemical modifiers of oncogene-regulated hematopoietic differentiation.
- AML1-ETO mediates hematopoietic self-renewal and leukemogenesis through a COX/β-catenin signaling pathway.
- Newborn Screening for Glutaric Aciduria-II: The New England Experience.
- Mechanisms underlying generation of gradients in gene expression within the intestine: an analysis using transgenic mice containing fatty acid binding protein-human growth hormone fusion genes.
- The corepressor Tle4 is a novel regulator of murine hematopoiesis and bone development.
- Coenzyme Q10 and immunity: A case report and new implications for treatment of recurrent infections in metabolic diseases.
- Tle1 tumor suppressor negatively regulates inflammation in vivo and modulates NF-κB inflammatory pathway.
- IQSEC2 and X-linked syndromal intellectual disability.
- TLE4 regulation of wnt-mediated inflammation underlies its role as a tumor suppressor in myeloid leukemia.
- The human and rodent intestinal fatty acid binding protein genes. A comparative analysis of their structure, expression, and linkage relationships.
- The nucleotide sequence of the rat liver fatty acid-binding protein gene. Evidence that exon 1 encodes an oligopeptide domain shared by a family of proteins which bind hydrophobic ligands.
- The cellular retinol binding protein II gene. Sequence analysis of the rat gene, chromosomal localization in mice and humans, and documentation of its close linkage to the cellular retinol binding protein gene.
- Rat cellular retinol-binding protein II: use of a cloned cDNA to define its primary structure, tissue-specific expression, and developmental regulation.
- Human liver fatty acid binding protein. Isolation of a full length cDNA and comparative sequence analyses of orthologous and paralogous proteins.
Dr. David Alan Sweetser MD's Practice location
Dr. David Alan Sweetser MD's reviews
Write ReviewPatient Experience with Dr. Sweetser
Recommended Articles
- Feds Appropriate $10M to Lupus Foundation for Research
The Lupus Foundation of America estimates that at least five million people worldwide suffer from any type of lupus. One and a half million of these patients are American women who are at childbearing age, and almost all experience fatigue, pain, cognitive and physical issues, hair loss, and several...
- Ovarian Cancer: Why a Second Opinion Is Essential
You know how crucial early detection is when it comes to ovarian cancer. Eighty-five percent of the time when women are diagnosed they are at a late stage and have a decreased likelihood of survival.The fact that this diagnosis needs to come quickly is the first area of concern. There isn’t much...
- Purpura
PurpuraPurpura refers to purple-colored spots that are usually seen on the skin, including mucous membranes and other organs. It is also called skin hemorrhages or blood spots.Purpura is usually recognized when there is pooling of blood under the skin due to ruptured small blood vessels. The size of...
- How Is Leukemia Diagnosed?
Leukemia in its early stages may present no signs or symptoms, as these only appear when the leukemia cells have taken over a large number of normal blood cells. A person with leukemia is very lucky indeed if early-stage detection occurs incidentally, through a routine blood test or one done for...
- Study Finds 3% of Pediatric Non-Hodgkin Lymphoma Cases Are Transplant Recipients
Lymphoma is a blood cancer that affects both children and adults.Lymphoma begins its growth in the lymphatic white blood cells of the lymph system. This system is a major warrior in fighting off infections and diseases. It is part of the body’s immunity team.The lymph system loops throughout the...
- Potential Causes of Leukopenia
IntroductionA decrease in the number of white blood cells (WBCs) is referred to as leukopenia. There are several causes for leukopenia. It may be due to certain drugs, cancer, radiation and chemotherapy for cancer, stem cell transplant, surgery, steroids, or autoimmune disorders. The immune system...
Nearby Providers
- Dr. Mary Stephanie Huang MD55 Fruit Street Yaw 8 B Boston MA 02114
- Dr. Eric Franklin Grabowski MD SCD55 Fruit St Boston MA 02114
- Dr. Daniel P. Kronish MD66 Revere St Boston MA 02114
- Dr. David Henry Ebb MD55 Fruit St, Yaw 8b Boston MA 02114
- Dr. Katja G. Weinacht M.D.Massachusetts General Hospital Boston MA 02114
- Dr. Lara Emily Davis MDMassachusetts General Hospital Boston MA 02114